Clinical efficacy and tolerability of Gosha-jinki-gan, a Japanese traditional herbal medicine, for nocturia

Hiroshi Yagi ； Kojiro Nishio ； Ryo Sato ； Gaku Arai ； Shigehiro Soh ； Hiroshi Okada

《Journal of Traditional and Complementary Medicine》 6卷1期 (2016/01) Pp. 102-105

https://doi.org/10.1016/j.jtcme.2014.11.021

摘要

We evaluated the efficacy and tolerability of Gosha-jinki-gan (GJG; 濟生腎氣丸jì shēng shèn qì wán) in 30 cases of nocturia (夜尿yè niào) unresponsive to α1-blockers or antimuscarinic drugs. All patients received GJG extract powder (2.5 g) three times a day for 12 weeks as an add-on therapy to α1-blockers or antimuscarinic drugs. Subjective outcomes assessed by the International Prostate Symptom Score-quality of life, and the benign prostatic hyperplasia impact index and objective outcomes assessed by urinary frequency and the urine production rate at night showed significant improvement after treatment. Moreover, other objective outcomes assessed by maximum flow rates, postvoid residual, serum human atrial natriuretic peptide levels, and urinary 8-hydroxy-2'-deoxyguanosine levels did not change. Adverse events were observed in 10% of cases; however, these events were mild. GJG appears to be a safe and effective potential therapeutic alternative for patients with nocturia unresponsive to α1-blockers or antimuscarinic drugs. Further clinical investigations are required to elucidate the precise pathophysio-logic mechanisms of GJG in nocturia.

關鍵字

Gosha-jinki-gan ； nocturia ； nocturnal polyuria index ； oxidative stress ； 8-OHdG level

參考文獻

Tikkinen KAO, Auvinen A, Johnson TM, et al. A systematic evaluation of factors associated with nocturia-the population based FINNO study. Am J Epidemiol. 2009;170:361-369.

Kobelt G, Borqstom F, Mattiasson A. Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia. BJU Int. 2003;91: 190-196.

Kupelian V, Rosen RC, Link CL, et al. Association of urological symptoms and chronic illness in men and women: contributions of symptom severity and duration-results from the BACH Survey. J Urol. 2009;181:694-699.

Klingler HC, Heidler H, Madersbacher H, Primus G. Nocturia: an Austrian study on the multifactorial etiology of this symptom. Neurourol Urodyn. 2009;28:427-431.

Hirayama A, Fujimoto K, Akiyama T, Hirao Y. Decrease in nocturnal urinary levels of arginine vasopressin in patients with nocturnal polyuria. Urology. 2006;68:98-102.